CausalSentinel

Protein Dossier — REG1A (Lithostathine-1-alpha)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Non-cancer illness code self-reported: pernicious anaemia 0.00121 0.000412 0.00326 Inverse variance weighted 2 cis NA
Non-cancer illness code self-reported: pernicious anaemia 0.00121 0.000412 0.00326 Inverse variance weighted 2 trans NA
Alcohol intake frequency 0.0252 0.0109 0.0213 Inverse variance weighted 2 cis NA
Alcohol intake frequency 0.0252 0.0109 0.0213 Inverse variance weighted 2 trans NA
Non-cancer illness code self-reported: vitiligo 0.000281 0.000126 0.0257 Inverse variance weighted 2 cis NA
Non-cancer illness code self-reported: vitiligo 0.000281 0.000126 0.0257 Inverse variance weighted 2 trans NA
Mean cell haemoglobin concentration -0.0291 0.0132 0.0278 Wald ratio 1 cis NA
Mean cell haemoglobin -0.0808 0.0396 0.0415 Wald ratio 1 cis NA
Internalizing problems -0.174 0.0857 0.0427 Wald ratio 1 cis NA
ER-negative Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) -0.0692 0.0365 0.058 Inverse variance weighted 2 cis NA
ER-negative Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) -0.0692 0.0365 0.058 Inverse variance weighted 2 trans NA
Diagnoses - main ICD10: N40 Hyperplasia of prostate -0.00135 0.000716 0.0586 Inverse variance weighted 2 cis NA
…and 153 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).

3. GWAS Catalog results — traits with signal at this locus

25 association rows across 14 traits (21 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating REG1A levels 2e-379 rs11126696 2 GCST90860433 no MR -> candidate analysis
REG1A protein levels 2e-311 rs76841471 5 GCST90470447 no MR -> candidate analysis
REG1B protein levels 7e-207 rs76841471 3 GCST90470448 no MR -> candidate analysis
Lithostathine-1-alpha levels 2e-91 rs76841471 4 GCST90248306 no MR -> candidate analysis
Lithostathine-1-beta levels 2e-86 rs11126696 2 GCST90248307 no MR -> candidate analysis
REG3A protein levels 2e-37 rs12990484 1 GCST90470449 no MR -> candidate analysis
Serum levels of protein REG1A 3e-25 rs76841471 1 GCST90087370 no MR -> candidate analysis
Cerebrospinal fluid protein REG1A levels 3e-18 rs76841471 1 GCST90945040 no MR -> candidate analysis
Lithostathine-1-beta (analyte X16770.3) levels 1e-16 rs76841471 1 GCST90422860 no MR -> candidate analysis
Cerebrospinal fluid protein REG1B levels 2e-16 rs11126696 1 GCST90944880 no MR -> candidate analysis
Progression free survival in epithelial ovarian cancer treat 2e-6 rs2070707 1 GCST012474 no MR -> candidate analysis
Complement factor H-related protein 2 levels 4e-6 rs205549 1 GCST90026530 no MR -> candidate analysis
…and 2 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 404 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
focal segmental glomerulosclerosis 0.195 established (curated) no MR -> candidate analysis
smoking initiation 0.144 common-variant locus no MR -> candidate analysis
obesity disorder 0.121 common-variant locus no MR -> candidate analysis
pyogenic granuloma 0.121 common-variant locus no MR -> candidate analysis
substance abuse 0.105 common-variant locus no MR -> candidate analysis
attention deficit-hyperactivity disorder 0.105 common-variant locus no MR -> candidate analysis

Of the 6 rows above, 6 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=2.1e-07, LOEUF=1.41 — LoF-tolerant
GWAS Catalog 55 unique SNPs / 110 rows
ClinVar 44 records; 2 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance